Market Cap : 72.82 B | Enterprise Value : 74.28 B | PE Ratio : 25.14 | PB Ratio : 2.60 |
---|
NAS:CME has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CME has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CME Group's enterprise value is $74,284 Mil. CME Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $4,217 Mil. Therefore, CME Group's EV-to-EBITDA for today is 17.62.
The historical rank and industry rank for CME Group's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of CME Group was 26.09. The lowest was 3.99. And the median was 15.24.
CME's EV-to-EBITDA is ranked worse thanEV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-15), CME Group's stock price is $202.60. CME Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $8.060. Therefore, CME Group's PE Ratio for today is 25.14.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The historical data trend for CME Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Financial Data & Stock Exchanges subindustry, CME Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Capital Markets industry and Financial Services sector, CME Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where CME Group's EV-to-EBITDA falls into.
CME Group's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 74283.922 | / | 4217 | |
= | 17.62 |
CME Group's current Enterprise Value is $74,284 Mil.
CME Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,217 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
CME Group's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 202.60 | / | 8.060 | |
= | 25.14 |
CME Group's share price for today is $202.60.
CME Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of CME Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Mccourt Timothy Francis | officer: Sr MD Global Head Equity & FX | 20 S WACKER DRIVE CHICAGO IL 60606 |
Fitzpatrick Lynne | officer: Sr MD Deputy CFO | 20 S WACKER DRIVE CHICAGO IL 60606 |
Sprague Suzanne | officer: Sr MD Global Head of Clearing | 20 SOUTH WACKER DRIVE 18S CHICAGO IL 60606 |
Dennis Michael G. | director | 20 S. WACKER DR. CHICAGO IL 60606 |
Maloney Patrick W | director | 20 S. WACKER DR. CHICAGO IL 60201 |
Mulchrone Patrick J | director | 20 S. WACKER DR. CHICAGO IL 60606 |
Seifu Rahael | director | 20 S. WACKER CHICAGO IL 60606 |
Harris Yra G | director | 20 S. WACKER DR CHICAGO IL 60606 |
Lockett Phyllis M | director | 20 S. WACKER DR. CHICAGO IL 60606 |
Tierney Robert J Jr | director | 20 S. WACKER DR. CHICAGO IL 60606 |
Kaye Daniel G | director | 1742 APPLEBY ROAD INVERNESS IL 60067 |
Spencer Michael A | director | 20 S. WACKER DR. CHICAGO IL 60606 |
Lucas Deborah J | director | C/O ANTHRACITE CAPITAL, INC. 40 EAST 52ND STREET NEW YORK NY 10022 |
Hertshten Gedon | director | 20 S. WACKER DR. CHICAGO IL 60606 |
Winkler Julie | officer: Chief Commercial Officer | 20 S. WACKER DR. CHICAGO IL 60606 |
From GuruFocus
Other Sources
By Zacks 2022-03-24
By Zacks 2022-01-06
By Zacks 2022-03-30
By Zacks 2022-02-10
By Zacks 2022-02-03
By Zacks 2022-02-08
By Zacks 2021-12-30
By Zacks 2022-02-04
By Zacks 2022-02-09
By Zacks 2022-02-09
By Zacks 2022-01-11
By Zacks 2022-03-17
By tipranks.com 2022-04-05